Small Caps Today

Pharma

6 Articles
NanoViricides Recent Clinical Updates and Milestones Highlight Potential Investor Opportunities
FeaturedPharma
s
scdadmin·Feb 15, 2024

NanoViricides Recent Clinical Updates and Milestones Highlight Potential Investor Opportunities

6' read
Decoded: Why Did Johnson & Johnson Spend $2 billion To Acquire Ambrx Biopharma?
Market MoversPharma
s
scdadmin·Jan 20, 2024

Decoded: Why Did Johnson & Johnson Spend $2 billion To Acquire Ambrx Biopharma?

6' read
TG Therapeutics: Is It Time to Invest In This Biotech Player After The Unprecedented 36.4% Jump?
BreakingMarket MoversPharma
s
scdadmin·Nov 09, 2023

TG Therapeutics: Is It Time to Invest In This Biotech Player After The Unprecedented 36.4% Jump?

6' read
NanoViricides Gets Big Funding Boost From CEO Dr. Anil Diwan Prior To IND Application
FeaturedPharma
s
scdadmin·Jan 07, 2020

NanoViricides Gets Big Funding Boost From CEO Dr. Anil Diwan Prior To IND Application

5' read
NanoViricides: Grab This Biopharma Player While Inexpensive
BiotechFeaturedPharmaResearch
s
scdadmin·Dec 17, 2019

NanoViricides: Grab This Biopharma Player While Inexpensive

8' read
1globe Capital Llc. Picked Up Exelixis Inc. (NASDAQ:EXEL) Shares
BusinessFeaturedNewsPharma
s
scdadmin·Nov 28, 2018

1globe Capital Llc. Picked Up Exelixis Inc. (NASDAQ:EXEL) Shares

2' read

Discover top 10 categories

Let's explore the most popular categories

Featured

263 Articles

News

239 Articles

Market Movers

165 Articles

Business

68 Articles

Breaking

49 Articles

Tech

33 Articles

Video

20 Articles

Podcast

20 Articles

Biotech

18 Articles

Research

13 Articles

Join our newsletter 🎉

Read and share new perspectives on just about any topic. Everyone’s welcome.
  • 01Create a free account.
  • 02Write your stories.
subsc